Results 151 to 160 of about 189,087 (191)
Some of the next articles are maybe not open access.
Treat and extend versus PRN in diabetic retinopathy
Acta Ophthalmologica, 2016SummaryVascular endothelial growth factor (VEGF) plays a key role in the pathogenesis of the neo‐vascular age related macular degeneration (nAMD) and the ischemic retinal microangiopathies. Targeting VEGF in retinal diseases became an effective therapeutic option.To optimize the benefit of risk ratio and cost effectiveness of anti‐VEGF agents, a number
openaire +1 more source
Treat and extend regimen for diabetic macular oedema—a systematic review and meta-analysis
Graefe's Archive for Clinical and Experimental Ophthalmology, 2022Various treatment regimens are currently practiced in the treatment of CI-DMO (centre-involving diabetic macular oedema). In recent years, there has been a growing body of evidence supporting a treat and extend (T&E) regimen for DMO which offers the promise of comparable visual and anatomical outcomes while reducing injection burden. This meta-analysis
Sheng Yang Lim +6 more
openaire +2 more sources
Fertility and Sterility, 2001
To determine if extended treatment with doxycycline before and after an in vitro fertilization (IVF) procedure can minimize the detrimental effect of a hydrosalpinx.Retrospective analysis.University IVF program.Patients undergoing IVF, including 17 with a hydrosalpinx, 25 with adhesions or proximal tubal occlusion, and 22 with endometriosis or ...
B S, Hurst +3 more
openaire +2 more sources
To determine if extended treatment with doxycycline before and after an in vitro fertilization (IVF) procedure can minimize the detrimental effect of a hydrosalpinx.Retrospective analysis.University IVF program.Patients undergoing IVF, including 17 with a hydrosalpinx, 25 with adhesions or proximal tubal occlusion, and 22 with endometriosis or ...
B S, Hurst +3 more
openaire +2 more sources
TREAT-AND-EXTEND REGIMEN USING RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
Retina, 2017To investigate the efficacy of a treat-and-extend regimen (TER) using ranibizumab to treat polypoidal choroidal vasculopathy (PCV).We retrospectively reviewed the medical records of 29 patients with PCV, who had been treated with a TER for 1 year. The primary outcome was the proportion of eyes that did not lose ≥3 best-corrected visual acuity (BCVA ...
Kang Yeun, Pak +3 more
openaire +2 more sources
Treat and extend protocol outcomes in diabetic macular edema: A narrative review
American Journal of Ophthalmic Clinical Trials, 2022The objective of this study was to pool available data on change in visual acuity, number of injections, and change in central subfield thickness as reported by treat and extend (T&E) regimens for diabetic macular edema (DME) compared to monthly and pro re nata (PRN) regimens.
Param Bhatter +6 more
openaire +1 more source
Graefe's Archive for Clinical and Experimental Ophthalmology, 2017
To evaluate the effects of aflibercept therapy using a treat-and-extend regimen on treatment-naïve polypoidal choroidal vasculopathy (PCV).In a retrospective interventional case series of 58 eyes of 58 patients with PCV, we assessed best-corrected visual acuity (BCVA), central macular thickness (CMT), central choroidal thickness (CCT), and number of ...
Dan, Călugăru, Mihai, Călugăru
openaire +4 more sources
To evaluate the effects of aflibercept therapy using a treat-and-extend regimen on treatment-naïve polypoidal choroidal vasculopathy (PCV).In a retrospective interventional case series of 58 eyes of 58 patients with PCV, we assessed best-corrected visual acuity (BCVA), central macular thickness (CMT), central choroidal thickness (CCT), and number of ...
Dan, Călugăru, Mihai, Călugăru
openaire +4 more sources
A benign hepatocellular adenoma treated by extended right lobectomy.
Annales chirurgiae et gynaecologiae. Supplementum, 1976A 19-YEAR-OLD WOMAN WITH A LARGE BENIGN HEPATOCELLULAR ADENOMA IS PRESENTED. The initial symptom was continuous anaemia demanding transfusions twice a month. Coeliac angiography revealed the hepatic tumour, which was thought to be malignant. Angiography produced permanent paraplegia as a complication.
A, Sivula, M, Lempinen
openaire +2 more sources
Isolated Kratom Use Disorder Treated With Extended-Release Buprenorphine Taper
Journal of Addiction MedicineAbstract This case report highlights a 36-year-old male without history of psychiatric disease, chronic pain, or substance use disorder who developed severe substance use disorder per Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria to kratom.
Benjamin B, Swart +2 more
openaire +2 more sources
Pharmacology Biochemistry and Behavior, 2008
A monthly extended-release formulation of the opioid antagonist naltrexone (XR-NTX) is approved for treatment of alcohol dependence. There is little research regarding overriding chronic (>21 days) competitive opioid receptor blockade with opioids for acute pain.
Reginald L, Dean +8 more
openaire +2 more sources
A monthly extended-release formulation of the opioid antagonist naltrexone (XR-NTX) is approved for treatment of alcohol dependence. There is little research regarding overriding chronic (>21 days) competitive opioid receptor blockade with opioids for acute pain.
Reginald L, Dean +8 more
openaire +2 more sources
The itinerant oscillator treated and extended in terms of a mori continued fraction
Chemical Physics Letters, 1977Abstract The angular velocity and orientational autocorrelation function of a disk are evaluated using a four-variable Mori formalism. It is pointed out that the equivalent three-variable formalism is formally identical to the inertia-corrected itinerant oscillator model developed recently by Coffey et al.
openaire +1 more source

